GILD · News · 20260912N

Revenue Performance and Dividend

GILEAD SCIENCES, INC. · 2026-09-12 · Importance 37 · Surprise 6 · In source text

Gilead Sciences reported quarterly revenue of $7.8 billion, exceeding analyst expectations. Adjusted EPS was negative $6.75 for the quarter and also exceeded analyst expectations. The company declared a quarterly dividend of $0.82 per share.

Key facts

• Gilead Sciences reported quarterly revenue of $7.8 billion. source
• Gilead Sciences declared a quarterly dividend of $0.82 per share. source
• Sequoia Financial Advisors LLC increased its stake in Gilead Sciences, Inc. by 16.9% in the second quarter, bringing its total holdings to 58,662 shares valued at $7.4 million. source
• The Manufacturers Life Insurance Company reduced its stake in Gilead Sciences by 11.9% in the second quarter, selling 148,344 shares. source
• Gilead Sciences reported an adjusted EPS of negative $6.75 for the quarter. source
• The Manufacturers Life Insurance Company still holds over 1 million shares of Gilead Sciences valued at $138.2 million. source
• Analysts generally maintain a "Moderate Buy" rating for GILD with an average price target of $158.78. source
• Analysts maintain a "Moderate Buy" rating for Gilead with an average price target of $158.78. source

Impact estimates